Menu
Global
简体中文
繁体中文
English
Home
About Us
Company Introduction
Development History
Leadership Team
Honor and Qualification
Industry Chain
Corporate Culture
R & D
Therapeutic Area
Technology Platform
Innovative Pipeline
Partnering
Products
Oncology
Digestive
NASH
Investor
Stock Information
Announcements and Circulars
Financial Report
Corporate governance
Investor Calendar
Company Information
Prospectus
Investor Relations
News
Contact Us
Address
Contact Information
Adverse drug reaction report
Join XZenith
Our Culture
Careers
Benefit
Talent Development
Employee style
Investor relations
Company announcement
Performance presentation
Performance promotion
Company announcement
All
All
2025
VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE MOVEMENTS
2025 ANNUAL REPORT - SUPPLEMENTAL INFORMATION
2026 INTERIM REPORT
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2026
VOLUNTARY ANNOUNCEMENT COMMERCIAL COOPERATION WITH INNOBIC FOR BIREOCICLIB IN THE THAILAND MARKET
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2026
DATE OF BOARD MEETING
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2026
VOLUNTARY ANNOUNCEMENT ARBITRATION AWARD AGAINST THE COMPANY
<
1
2
3
4
5
6
>
Home
About Us
+
Company Introduction
Development History
Leadership Team
Honor and Qualification
Industry Chain
Corporate Culture
R & D
+
Therapeutic Area
Technology Platform
Innovative Pipeline
Partnering
Products
+
Oncology
Digestive
NASH
Investor
+
Stock Information
Announcements and Circulars
Financial Report
Corporate governance
Investor Calendar
Company Information
Prospectus
Investor Relations
News
+
Contact Us
+
Address
Contact Information
Adverse drug reaction report
Join XZenith
+
Our Culture
Careers
Benefit
Talent Development
Employee style